Cambridge-based global, science-led biopharmaceutical company AstraZeneca and German manufacturer of viral vaccines and biologics IDT Biologika have signed a Letter of Intent (LOI) to increase Europe’s Covid-19 vaccine manufacturing capability.
11 Feb 2021
21 Jan 2021
Akron Biotechnology (Akron Biotech) has signed an exclusive global agreement with Swiss-based Octapharma, to manufacture virally inactivated Human AB Serum for the cell therapy market.
23 Sep 2020
05 Dec 2019
AWS announces strategic collaboration with Novartis to accelerate digital transformation of its business operations
Amazon Web Services, Inc. (AWS), an Amazon.com company (NASDAQ: AMZN), announced a multi-year strategic collaboration with Novartis to reimagine this leading pharmaceutical company’s core pharmaceutical manufacturing, supply chain, and delivery operations using AWS’s portfolio of cloud services.
11 Mar 2019
Data sharing specialist Nallian said that it will launch the Global Pharma Tracker, the world's first data sharing platform for end-to-end tracking and monitoring of temperature-controlled pharma shipments, at the IATA World Cargo Symposium in Singapore.
07 Feb 2019
PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global biopharmaceutical industry, has announced the expansion of its bottling line capacity at its Commercial Packaging site in Rockford, IL.
22 Jan 2019
PCI Pharma Services (PCI) has announced further investment in its expansive infrastructure for packaging of controlled substances, complementing its capacity for blister packaging, a key tenet of recent calls for dispensing opioid prescriptions in limited quantity unit dose packaging as a tactic to combat substance misuse.
21 Jan 2019
Swiss drugmaker Novartis has selected Kinaxis’ RapidResponse platform as its new supply chain planning system to accelerate technical operation transformation.
17 Jan 2019
Schott, a Germany-based manufacturer of glass and glass-ceramics, has announced an investment of €300m in the coming three years in its pharmaceutical packaging business.
08 Jan 2019
PCI Pharma Services (PCI) will invest over $20m to expand its biotech technologies, including advanced injectable delivery forms, at multiple locations across the world, to meet demand for biotech packaging.